Annual ROE
-33.21%
-0.61%-1.87%
December 31, 2023
Summary
- As of February 7, 2025, KYMR annual return on equity is -33.21%, with the most recent change of -0.61% (-1.87%) on December 31, 2023.
- During the last 3 years, KYMR annual ROE has risen by +10.32% (+23.71%).
- KYMR annual ROE is now -153.27% below its all-time high of 62.34%, reached on December 31, 2018.
Performance
KYMR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-27.19%
+2.91%+9.67%
September 30, 2024
Summary
- As of February 7, 2025, KYMR quarterly return on equity is -27.19%, with the most recent change of +2.91% (+9.67%) on September 30, 2024.
- Over the past year, KYMR quarterly ROE has increased by +6.55% (+19.41%).
- KYMR quarterly ROE is now -159.75% below its all-time high of 45.51%, reached on March 31, 2020.
Performance
KYMR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
KYMR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.9% | +19.4% |
| 3 y3 years | +23.7% | +19.4% |
| 5 y5 years | -153.3% | +19.4% |
KYMR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.2% | at low | at high | +25.4% |
| 5 y | 5-year | -159.9% | +23.7% | -159.8% | +91.6% |
| alltime | all time | -153.3% | +23.7% | -159.8% | +91.6% |
Kymera Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -27.19%(-9.7%) |
| Jun 2024 | - | -30.10%(-6.6%) |
| Mar 2024 | - | -32.22%(-4.5%) |
| Dec 2023 | -33.21%(+1.9%) | -33.74%(-7.5%) |
| Sep 2023 | - | -36.47%(+6.4%) |
| Jun 2023 | - | -34.28%(-1.2%) |
| Mar 2023 | - | -34.70%(+2.6%) |
| Dec 2022 | -32.60% | -33.81%(+0.3%) |
| Sep 2022 | - | -33.70%(-2.0%) |
| Jun 2022 | - | -34.38%(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -32.50%(+14.2%) |
| Dec 2021 | -26.96%(-38.1%) | -28.47%(+15.0%) |
| Sep 2021 | - | -24.76%(+3.1%) |
| Jun 2021 | - | -24.02%(-11.1%) |
| Mar 2021 | - | -27.02%(-9.9%) |
| Dec 2020 | -43.53%(-178.5%) | -29.98%(-27.0%) |
| Sep 2020 | - | -41.09%(-87.3%) |
| Jun 2020 | - | -322.93%(-809.6%) |
| Mar 2020 | - | 45.51%(+47.7%) |
| Dec 2019 | 55.43%(-11.1%) | 30.82% |
| Dec 2018 | 62.34% | - |
FAQ
- What is Kymera Therapeutics annual return on equity?
- What is the all time high annual ROE for Kymera Therapeutics?
- What is Kymera Therapeutics annual ROE year-on-year change?
- What is Kymera Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly ROE year-on-year change?
What is Kymera Therapeutics annual return on equity?
The current annual ROE of KYMR is -33.21%
What is the all time high annual ROE for Kymera Therapeutics?
Kymera Therapeutics all-time high annual return on equity is 62.34%
What is Kymera Therapeutics annual ROE year-on-year change?
Over the past year, KYMR annual return on equity has changed by -0.61% (-1.87%)
What is Kymera Therapeutics quarterly return on equity?
The current quarterly ROE of KYMR is -27.19%
What is the all time high quarterly ROE for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly return on equity is 45.51%
What is Kymera Therapeutics quarterly ROE year-on-year change?
Over the past year, KYMR quarterly return on equity has changed by +6.55% (+19.41%)